Evidence map›Paper›PMID 20664073›Full record

ReviewPhysiological reviews2010

Muscle KATP channels: recent insights to energy sensing and myoprotection.

Thomas P Flagg, Decha Enkvetchakul, Joseph C Koster, Colin G Nichols

Open access · greenAbstract readReview
In one paragraph

Review in Physiological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 1 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 1 synthesis or guideline pooled it, 266 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. HHandbook of experimental pharmacology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Andrology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Non-radioactive RbMethods in molecular biology (Clifton, N.J.) · 2024
    Article
  19. Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome KThe Journal of pharmacology and experimental therapeutics · 2023
    Article
  20. Review

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thomas P FlaggDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. Thomas.Flagg@usuhs.mil
Decha Enkvetchakul
Joseph C Koster
Colin G Nichols
Uniformed Services University of the Health Sciences · US

Funding

ATP-SENSITIVE POTASSIUM CHANNELS IN THE HEARTR01HL045742 · NHLBI · WASHINGTON UNIVERSITY · PI NICHOLS, COLIN G · 1991 to 2016
$3.6M
SUR1 (ABCC8) AND ATRIAL KATP CHANNELSR01HL095010 · NHLBI · WASHINGTON UNIVERSITY · PI NICHOLS, COLIN G · 2009 to 2017
$3.4M
NHLBI NIH HHS HL-45742NHLBI NIH HHS HL-95010NHLBI NIH HHS R01 HL045742NHLBI NIH HHS R01 HL095010
6 · The paper itself

Abstract

ATP-sensitive potassium (K(ATP)) channels are present in the surface and internal membranes of cardiac, skeletal, and smooth muscle cells and provide a unique feedback between muscle cell metabolism and electrical activity. In so doing, they can play an important role in the control of contractility, particularly when cellular energetics are compromised, protecting the tissue against calcium overload and fiber damage, but the cost of this protection may be enhanced arrhythmic activity. Generated as complexes of Kir6.1 or Kir6.2 pore-forming subunits with regulatory sulfonylurea receptor subunits, SUR1 or SUR2, the differential assembly of K(ATP) channels in different tissues gives rise to tissue-specific physiological and pharmacological regulation, and hence to the tissue-specific pharmacological control of contractility. The last 10 years have provided insights into the regulation and role of muscle K(ATP) channels, in large part driven by studies of mice in which the protein determinants of channel activity have been deleted or modified. As yet, few human diseases have been correlated with altered muscle K(ATP) activity, but genetically modified animals give important insights to likely pathological roles of aberrant channel activity in different muscle types.

Indexed as

AnimalsATP-Binding Cassette TransportersCardiovascular DiseasesHeartHumansKATP ChannelsMolecular StructureMuscle, SkeletalMuscle, SmoothMuscle, Smooth, VascularMutationMyocardiumPotassium Channels, Inwardly RectifyingReceptors, DrugSulfonylurea ReceptorsVasomotor SystemABCC8 protein, humanAbcc8 protein, mouseABCC9 protein, humanATP-Binding Cassette TransportersKATP ChannelsPotassium Channels, Inwardly RectifyingReceptors, DrugSulfonylurea Receptors

Identifiers

PMID20664073
PMCPMC3125986
OpenAlexW1999850650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.